Cite
APA Citation
Hurry, M., Zhou, Z., Zhang, J., Zhang, C., Fan, L., Rebeira, M., & Xie, J. (2016). cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada. Journal of medical economics, 19, 936–944. http://access.bl.uk/ark:/81055/vdc_100035835955.0x000055